SEPTEMBER 8, 2008
MONDAY - HALL A |
08.00-09.00 |
Registration |
09.00-09.10 |
Opening Ceremony |
09.15-10.00 |
Plenary Lecture
Prof. Leslie Z. Benet
University of California at San Francisco, USA
The effect of efflux transporters on the pharmacokinetics of orally administered drugs |
10.00-10.20 |
Coffee Break |
10.20-10.50 |
Prof. Patrick Couvreur
Université Paris-Sud, FR
Nanotechnologies: intelligent design to treat complex diseases |
10.50-11.20 |
Prof. Alexander Kabanov
University of Nebraska Medical Center, USA
Nanomedicine from Bench to Bedside |
11.20-11.50 |
Prof. Erhan Pişkin
Hacettepe University, TR
Intelligent polymers in drug delivery |
11.50-12.00 |
Group Photo |
12.00-13.30 |
Lunch |
13.30-14.00 |
Dr. Maurice Sofeir
Sanofi Aventis , FR
The impact of nanotechnology in pharmaceutics
|
14.00-14.30 |
Prof. Oya Alpar
University of London, UK
Recent advances in chitosan-based vectors as delivery systems for biotherapeutics
|
14.30-15.00 |
Prof. Yılmaz Çapan
Hacettepe University, TR
Brain drug targeting |
15.00-15.30 |
Coffee Break |
15.30-16.00 |
Prof. Vladimir Torchillin
Northeastern University, Center for Pharmaceutical Biotechnology and Nanomedicine, USA
Nanomedicine for cancer diagnosis and therapy |
16.00-16.30 |
Prof. Michael Jay
University of North Carolina, USA
Nanotemplate engineered nanoparticles |
16.30-17.00 |
Prof. Keji Itaka
The University of Tokyo, JP
Overcoming Cellular Plasma Membrane Barriers for Efficient siRNA Delivery by Surface Modified and Internally Cationic PAMAM Dendrimers |
17.00-17.30 |
Prof. Tamara Minko
The State University of New Jersey, USA
Pharmacogenomic analysis on cell activity of biocompatible cationic polymer for gene delivery |
SEPTEMBER 8, 2008
MONDAY - HALL B
Industrial Session on Biotech and Biosimilar Products
Chaired by:
Dr. Mahmut Tokaç
General Director of Pharmaceuticals and Pharmacy, Turkish Ministry of Health, Turkey
Prof. Gary Walsh
University of Limerick, Ireland |
| 10:20-10:40 |
Opening ceremony
Dr. Mahmut Tokaç
GDPP, Turkey
Prof. Gary Walsh
University of Limerick, IE |
| 10:40-11:20 |
Prof. Gary Walsh
University of Limerick, IE
Biosimilars, background and introduction |
| 11:20-11:50 |
Dr. Jean-Louis Prugnaud (FR)
L’Hopital Saint Antoine, FR
“European regulations in the context of biosimilars' |
| 11:50-12:00 |
Group Photo |
| 12:00-13:30 |
Lunch |
| 13:30-14:00 |
Prof. Salomon Stavchansky
University of Texas,USA
Lecture title to be announced |
| 14:00-14:30 |
Dr. Connor O’Dea
General Manager, Genemedix
Process Development and Manufacture of a Biosimilar Product |
| 14:30-15:00 |
Dr. Andreas Premstaller
Sandoz Biopharmaceuticals
Development of a biosimilar human product: Omnitrope |
| 15:00-15:30 |
Coffee break |
| 15:30-16:00 |
Dr. Carsten Brockmeyer
Sandoz Biopharmaceuticals, D
Biosimilars, a case study: 'Erythropoietin'. |
| 16:30-17:00 |
Dr. Alaine Cuiné
BD Medical & Pharmaceutical Systems, FR
Which injectable formulations for tomorrow’s biotechnologies? |
| 17:00-17:30 |
Dr. Thomas Bols
Director Government Affairs, Europe
Amgen, BE
“Biosimilars: issues to be addressed for proper entry into clinical practice” |
| 17:30-17:45 |
Panel Discussion |
| 17:45 |
Closing of session |
